Ownership as of September 30, 2021. Ten largest shareholders.
NameSeries A sharesSeries B sharesShare capital %Voting rights %
ANNWALL & ROTHSCHILD INVESTMENTS AB377 736510 4787.9129.32
SIX SIS AG, W8IMY01 186 08710.578.11
FJÄRDE AP-FONDEN01 120 0009.987.66
SWEDBANK ROBUR NY TEKNIK BTI0579 1725.163.96
AMF AKTIEFOND SMÅBOLAG0501 5854.473.43
TREDJE AP-FONDEN0501 5794.473.43
UNIONEN0322 1962.872.20
CBNY-NORGES BANK0321 9892.872.20
DANGOOR, DAVID0306 4212.732.10
ÅLANDSBANKEN I ÄGARES STÄLLE0261 7592.331.79
Sub-total3777365 611 26653.3664.20
Other shareholders05 237 18246.6435.80
Total37773610848448100.00100.00
Source: Euroclear Sweden AB
The total registered share capital of Infant Bacterial Therapeutics AB consists of 377,736 class A shares with 10 votes per share and 10,848,448 class B shares with one vote per share, in total 11,226,184 shares.